Status:
COMPLETED
The Efficacy of Botulinum Toxin vs. Corticosteroid for the Treatment of Refractory Plantar Fasciitis
Lead Sponsor:
Western Institute for Veterans Research
Conditions:
Plantar Fasciitis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
This single-blinded, randomized-controlled trial compares the efficacy of ultrasound-guided onabotulinumtoxinA (BTX-A) injections to the flexor digitorum brevis with current standard of care corticost...
Detailed Description
Treatment of plantar fasciitis is not well described in the current literature, often making management difficult for both providers and patients. Recent literature has suggested potential use of Onab...
Eligibility Criteria
Inclusion
- Diagnosed increased pain when pressure applied at the medial calcaneal tubercle
- X-ray negative for calcaneal fractures or tumors
- Patient with plantar fasciitis who have failed 6 weeks of non-operative treatment
Exclusion
- Prior botulinum toxin injections in the plantar fascia
- Any botulinum toxin injections in the past 3 months
- Cortisone injection in the plantar fascia in the previous 3 months
- Previous surgery on the plantar fascia
- Active workers compensation claim for plantar fasciitis
- Active infection or fever
- Botox or steroid allergy
- Pregnancy
- Current other treatment specific to the plantar fascia or intent to undergo during the trial
Key Trial Info
Start Date :
August 23 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 13 2024
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT05367271
Start Date
August 23 2022
End Date
September 13 2024
Last Update
April 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Salt Lake City Health Care System
Salt Lake City, Utah, United States, 84148